Meetings with patient organizations are one of the key pillars of building responsible biobanking. It is through direct dialogue with patients that we gain the clearest understanding of the questions, concerns, and expectations surrounding the idea of donating biological material for scientific research.
During our meeting with the patient organization La Vie La Vie, we discussed what biobanking means in practice and why it is playing an increasingly important role in advancing our understanding of diseases and the development of modern medicine. A biobank is not just laboratory infrastructure—it is a comprehensive system designed to securely, ethically, and systematically collect, store, and share biological material for research purposes. This enables projects focused on disease mechanisms, biomarker discovery, and the development of new therapeutic strategies.
We also dedicated significant attention to the concept of PPIE (Patient and Public Involvement and Engagement), which promotes the meaningful inclusion of patients and the public in the research process—not only as participants, but as active partners in shaping research directions and defining its relevance.
Meetings like this clearly demonstrate that progress in biomedical research is not driven solely by technology and procedures. At its core lies a strong relationship with the individuals whose health and lives are ultimately impacted by this work.
